Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee S Simon

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Nature Clinical Practice. Rheumatology|August 6, 2008
Do topical NSAIDs work?Lee S Simon
Nature Clinical Practice. Rheumatology|January 5, 2007
Frequency of COX2-inhibitor use in the clinic prior to market withdrawalsLee S Simon
Journal of Pain & Palliative Care Pharmacotherapy|March 30, 2010
Individual patient treatment use of unapproved drugs: a new option for the seriously illLee S Simon, Allan Green
Best Practice & Research. Clinical Rheumatology|July 10, 2003
Chronic pain and fibromyalgia: the regulatory perspectiveJames Witter, Lee S Simon
Arthritis Research & Therapy|March 18, 2006
Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of riskLawrence Goldkind, Lee S Simon
Cleveland Clinic Journal of Medicine|December 2, 2004
A world without Vioxx: to COX-2 or not to COX-2?Lee S Simon, Vibeke Strand
Current Rheumatology Reports|May 28, 2005
Perception of risk: the state of COX-2 selective inhibitorsLee S Simon, Vibeke Strand
Postgraduate Medicine|August 12, 2009
COX-2 selective inhibitors and heart healthLee S Simon, William B White
Pain Medicine (Malden, Mass.)|December 31, 2013
Advice from professional societies: appropriate use of NSAIDsAlexa Simon Meara, Lee S Simon
Arthritis Research & Therapy|September 20, 2005
Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balanceJeffrey S Borer, Lee S Simon
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Nature Clinical Practice. Rheumatology|August 6, 2008
Do topical NSAIDs work?Lee S Simon
Nature Clinical Practice. Rheumatology|January 5, 2007
Frequency of COX2-inhibitor use in the clinic prior to market withdrawalsLee S Simon
Journal of Pain & Palliative Care Pharmacotherapy|March 30, 2010
Individual patient treatment use of unapproved drugs: a new option for the seriously illLee S Simon, Allan Green
Best Practice & Research. Clinical Rheumatology|July 10, 2003
Chronic pain and fibromyalgia: the regulatory perspectiveJames Witter, Lee S Simon
Arthritis Research & Therapy|March 18, 2006
Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of riskLawrence Goldkind, Lee S Simon
Cleveland Clinic Journal of Medicine|December 2, 2004
A world without Vioxx: to COX-2 or not to COX-2?Lee S Simon, Vibeke Strand
Current Rheumatology Reports|May 28, 2005
Perception of risk: the state of COX-2 selective inhibitorsLee S Simon, Vibeke Strand
Postgraduate Medicine|August 12, 2009
COX-2 selective inhibitors and heart healthLee S Simon, William B White
Pain Medicine (Malden, Mass.)|December 31, 2013
Advice from professional societies: appropriate use of NSAIDsAlexa Simon Meara, Lee S Simon
Arthritis Research & Therapy|September 20, 2005
Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balanceJeffrey S Borer, Lee S Simon
Pageof 14